Liquid chromatography-mass spectrometry in evaluation of bioequivalence of two kinds of amlodipine besylate tablets
- Author:
Chao LIANG
1
Author Information
1. Department of General Surgery
- Publication Type:Journal Article
- Keywords:
Amlodipine;
Benzenesulfonates;
Biological availability;
Chromatography, high pressure liquid;
Pharmacokinetics;
Spectrum analysis, mass
- From:
Academic Journal of Second Military Medical University
2010;28(3):299-301
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To establish a liquid chromatography-mass spectrometry (LC-MS) method for determining the concentration of amlodipine besylate in human plasma and to evaluate the bioequivalence of 2 kinds of amlodipine besylate tablets. Methods: Twenty healthy male volunteers were enrolled into a single crossover study. A single dose of the suspension equivalent to 10 mg amlodipine besylate or a reference preparation was given in a crossover way. The plasma concentrations of amlodipine besylate were determined by LC-MS method in the volunteers at different time points; the pharmacokinetic parameters and relative bioavailability were calculated and the bioequivalence of the 2 preparations were evaluated. Results: The pharmacokinetic parameters for experimental and the reference preparations were: Cmax (6.21±1.88) vs (6.03±1.08) ng/ml; AUC0-120 (250.68±52.61) vs (246.14±52.11) ng h/ml; Tmax (6.0±2.3) vs (6.1±2.5) h; t1/2 (40.45±6.68) vs (43.74± 9.05) h, respectively. The linear range of the present method was 0.1-20.0 ng/ml; the lowest detectable concentration of amlodipine besylate was 0.1 ng/ ml. There was no significant difference in pharmacokinetic parameters between the 2 tablets. Conclusion: The present method is simple to use, fast, and accurate. The 2 preparations of amlodipine besylate are bioequivalent.
